How to use (dosage) GLP-1 agonists are typically injected subcutaneously, with some oral options like Rybelsus available
For understanding the stack this means: the order and the joint presence of both signals is mechanistically relevant, not just the sum of two individual doses
Driven by a 10-year, 3-step plan created and publicized by Novo Nordisk to build the ob*sity care market from scratch to maximize their GLP-1 weight loss drug profits (which Louise Adams and I will discuss in-depth on our podcast), we have seen a combination of factors including (but certainly not limited to): Astroturf patient-advocacy groups working hard to influence not just patient and provider behavior, but also public health messaging, government and policy Extremely sketchy research creating misleading messages everything from body size itself, to the realities of the drugs, to how much weight is regained when people go off the drugs and much, much more Education created by the weight loss industry delivered directly to healthcare providers Its no wonder that there is so much confusion about informed consent for these drugs
The TrimRx model is closer to a la carte: pay for the medication and clinician, source the rest yourself
Its onboarding flow, medication tiers, and follow-up model are described on Fridays' official website, and those details can change, so check them directly when you evaluate the program
The waste products produced are discharged more easily